Show simple item record

dc.contributor.authorBianchim, MS
dc.contributor.authorMcNarry, MA
dc.contributor.authorEvans, R
dc.contributor.authorThia, L
dc.contributor.authorBarker, AR
dc.contributor.authorWilliams, CA
dc.contributor.authorDenford, S
dc.contributor.authorMackintosh, KA
dc.date.accessioned2022-11-03T14:35:49Z
dc.date.issued2022-04-20
dc.date.updated2022-11-03T14:00:23Z
dc.description.abstractCommonly used cut-points may misclassify physical activity (PA) in people with cystic fibrosis (CF). The aim of this study was to develop and cross-validate condition-specific cut-points in children and adolescents with CF. Thirty-five children and adolescents with CF (15 girls; 11.6 ± 2.8 years) and 28 controls (16 girls; 12.2 ± 2.7 years), had their energy expenditure and triaxial acceleration measured during six daily activities of varying intensities. Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) were extracted using both GENEActiv (both wrists) and ActiGraph GT9X (both wrists and right waist) accelerometers. ROC curves were used to determine healthy and CF-specific raw acceleration cut-points for sedentary time (SED), moderate physical activity (MPA) and vigorous physical activity (VPA). The PA cut-points were generally lower in CF compared to controls for both ENMO (60.2–73.1 vs. 63.5–86.8 mg) and MAD (58.9–85.2 vs. 75.9–93.7 mg). These substantial inter-cut-point differences support the need for disease-specific cut-points.en_GB
dc.description.sponsorshipCystic Fibrosis Trusten_GB
dc.format.extent1-9
dc.identifier.citationPublished online 20 April 2022en_GB
dc.identifier.doihttps://doi.org/10.1080/1091367x.2022.2065919
dc.identifier.grantnumberRP-PG-0108-10011en_GB
dc.identifier.urihttp://hdl.handle.net/10871/131609
dc.identifierORCID: 0000-0001-8610-5417 (Barker, Alan R)
dc.identifierScopusID: 14008425100 | 57369449900 (Barker, Alan R)
dc.identifierResearcherID: AAF-7777-2020 (Barker, Alan R)
dc.identifierORCID: 0000-0002-1740-6248 (Williams, Craig A)
dc.identifierScopusID: 57201609242 (Williams, Craig A)
dc.identifierResearcherID: AAQ-8954-2020 (Williams, Craig A)
dc.language.isoenen_GB
dc.publisherRoutledgeen_GB
dc.rights© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectThresholden_GB
dc.subjectphysical activityen_GB
dc.subjectENMOen_GB
dc.subjectMADen_GB
dc.subjectyouthen_GB
dc.titleCalibration and Cross-validation of Accelerometry in Children and Adolescents with Cystic Fibrosisen_GB
dc.typeArticleen_GB
dc.date.available2022-11-03T14:35:49Z
dc.identifier.issn1091-367X
dc.descriptionThis is the final version. Available on open access from Routledge via the DOI in this recorden_GB
dc.descriptionData availability statement: The datasets generated and/or analysed during the current study are not publicly available due to GDPR regulations and to protect individual privacy but are available from the corresponding author on reasonable request.en_GB
dc.identifier.eissn1532-7841
dc.identifier.journalMeasurement in Physical Education and Exercise Scienceen_GB
dc.relation.ispartofMeasurement in Physical Education and Exercise Science
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-04-20
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-11-03T14:34:06Z
refterms.versionFCDVoR
refterms.dateFOA2022-11-03T14:35:55Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-04-20


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.